(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMULAÇÕES DE CANABINOIDES PARA O TRATAMENTO DE PSORÍASE

ArquivadaInvention PatentPCT · AU2018050047

Application data

Number

112019017011

Type

Invention Patent

Filing

01/24/2018

Publication

04/14/2020

PCT

AU2018050047

Progress at the INPI

  1. Filing01/24/18
  2. Publication04/14/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 01/24/2018 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/19/2021. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BOTANIX PHARMACEUTICALS, INC.

US

BOTANIX PHARMACEUTICALS LTD

AU

Inventors

E. C. (pessoa física)

US

M. C. (pessoa física)

US

Technical data

Priority claims

AU

2017900494 · 02/15/2017

US

62/459.387 · 02/15/2017

Abstract

Trata-se de uma composição farmacêutica que compreende um canabinoide e um siloxano, em que o canabinoide é dissolvido na composição.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Adição na publicação

#15.35

10/19/2021

RPI 2650

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

07/20/2021

RPI 2637

Arquivamento - Art. 33 da LPI

#11.1

05/04/2021

RPI 2626

Notificação de entrada na fase nacional - PCT

#1.3

04/14/2020

RPI 2571

Alteração de dados cadastrais

#1.1

08/27/2019

RPI 2538

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.